AGILE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4003 USD | +8.19% |
|
+8.84% | -79.47% |
| Mar. 28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
| Mar. 28 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M | MT |
Chart calendar Agile Therapeutics, Inc.
8ad18fd7002f8b599.kDxRBVOY2V8o3CSUTX18iEQOCDibg8AkOPtaKpgjfqw.8WopfBzBqRJR7kPHNxkJxhVrQ3Lh15RBCskObPoXTv3CVyJyGqmgFWS_EA~299ab14826eb16b213b83148a6a4094b
Upcoming events on Agile Therapeutics, Inc.
Past events on Agile Therapeutics, Inc.
| 2024-03-28 08:30 am | Q4 2023 Earnings Call |
| 2024-03-28 08:05 am | Q4 2023 Earnings Release |
| 2023-11-09 08:30 am | Q3 2023 Earnings Call |
| 2023-11-09 08:05 am | Q3 2023 Earnings Release |
| 2023-09-13 12:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-09 08:30 am | Q2 2023 Earnings Call |
| 2023-08-09 08:05 am | Q2 2023 Earnings Release |
| 2023-06-08 09:00 am | Annual General Meeting |
| 2023-05-11 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-11 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-22 04:30 pm | Q4 2022 Earnings Call |
| 2023-03-22 04:05 pm | Q4 2022 Earnings Release |
| 2023-03-08 | Extraordinary Shareholder Meeting |
| 2022-12-05 03:20 pm | RHK Capital Disruptive Growth Conference |
| 2022-11-07 04:30 pm | Q3 2022 Earnings Call |
| 2022-11-07 04:05 pm | Q3 2022 Earnings Release |
| 2022-09-13 10:00 am | H.C. Wainwright Global Investment Conference |
| 2022-08-11 04:30 pm | Interim 2022 Earnings Call |
| 2022-08-11 04:05 pm | Interim 2022 Earnings Release |
| 2022-07-13 11:00 am | Maxim Group M-Vest Virtual Conference - Panel |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,75 1,01 -25.59% | 4,10 4,10 -0.06% | 10,9 10,0 8.69% | 19,6 20,0 -2.26% |
|
EBITDA Million USD | Released Forecast Spread | -18,7 -17,3 -8.37% | -48,8 -51,1 4.55% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -18,9 -17,5 -7.93% | -49,1 -51,5 4.8% | -71,0 -64,1 -10.75% | -52,6 -48,9 -7.54% | -19,9 -19,0 -4.59% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,6 -17,4 -7.1% | -51,9 -54,4 4.6% | -74,9 -68,0 -10.09% | -30,1 -57,4 47.57% | -14,5 -12,7 -13.76% |
|
Net income Million USD | Released Forecast Spread | -18,6 -17,4 -7.1% | -51,9 -54,4 4.6% | -74,9 -68,0 -10.09% | -25,4 -52,7 51.79% | -14,5 -12,7 -13.76% |
|
EPS USD | Released Forecast Spread | -760 -704 -7.95% | -1 220 -1 285 5.06% | -1 540 -1 393 -10.53% | -59,0 -123 52.03% | -6,71 -5,92 -13.34% |
| Announcement Date | 20/02/20 | 01/03/21 | 30/03/22 | 22/03/23 | 28/03/24 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,51 1,51 0.18% | 1,76 1,22 43.87% | 2,13 1,98 7.32% | 3,00 2,33 28.65% | 4,00 3,13 27.87% | 3,81 3,40 12.25% | 5,50 4,63 18.95% | 6,66 6,35 4.87% | 3,62 4,07 -11.16% |
|
EBIT Million USD | Released Forecast Spread | -22,4 -17,2 -30.33% | -15,6 -17,5 10.77% | -11,4 -12,3 7.61% | -18,7 -16,7 -12.26% | -6,88 -8,75 21.44% | -6,71 -7,08 5.28% | -5,13 -5,94 13.7% | -4,00 -4,01 0.15% | -4,05 -3,18 -27.48% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,4 -18,1 -28.73% | -16,4 -17,9 8.23% | -12,2 -12,9 5.5% | -19,7 -17,2 -14.65% | -3,93 -9,05 56.61% | -5,39 -7,08 23.89% | -3,81 -6,11 37.65% | -0,80 -3,55 77.47% | -4,47 -2,72 -64.41% |
|
Net income Million USD | Released Forecast Spread | -23,4 -18,1 -28.73% | -11,8 -17,9 34.32% | -12,2 -12,9 5.5% | -19,7 -17,2 -14.65% | -3,93 -9,05 56.61% | -5,39 -7,08 23.89% | -3,81 -6,11 37.65% | -0,80 -3,55 77.47% | -4,47 -2,72 -64.41% |
|
EPS USD | Released Forecast Spread | -400 -300 -33.33% | -189 -300 37% | -136 -185 26.76% | -26,5 -22,0 -20.45% | -5,00 -11,0 54.55% | -5,91 -7,50 21.2% | -2,15 -4,95 56.52% | -0,27 -1,84 85.33% | -1,51 -0,92 -64.13% |
| Announcement Date | 30/03/22 | 12/05/22 | 11/08/22 | 07/11/22 | 22/03/23 | 11/05/23 | 09/08/23 | 09/11/23 | 28/03/24 |
More events
Past sector events for Agile Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AGRX Stock
- Calendar Agile Therapeutics, Inc.
